The COVID-19 pandemic has shown that it appears safe to relax restrictions on methadone, the oldest treatment drug for opioid addiction.
Here’s one more lesson from the COVID-19 pandemic: It appears safe to relax restrictions on methadone, the oldest and most stigmatized treatment drug for opioid addiction.
Early research shows it didn’t lead to surges of methadone overdoses or illegal sales. And the phone counseling that went along with take-home doses worked better for some people, helping them stay in recovery and get on with their lives.Advertisement Now, scientists are gathering information to put those rules — never rigorously tested — under scrutiny.of Yale University School of Medicine, who is among researchers studying the methadone rule changes. “If we roll these policies back post-COVID, it’s going to be devastating.”
Scott Mancini, 58, a retired truck driver in Providence, R.I., has been taking methadone for a heroin addiction since 1989. Before the pandemic change, Mancini could take home a six-day supply, requiring a weekly stop at the clinic.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Potential Endgame Scenarios for COVID-19 | Coronavirus in ContextWebMD's Chief Medical Officer, John Whyte, MD, speaks with Eli Adashi, MD, Professor, Medical Science, Brown University, about the possible endgame scenarios...
Weiterlesen »
Pac-12 says COVID-19 issues can result in forfeits in 2021Pac-12 teams that cannot play because of COVID-19 issues will likely be forced to forfeit games this season. The conference announced Thursday it is reinstituting its forfeiture policy after it modified its rules last season because of the pandemic. “If an institution is unable to play a contest through its own fault, it shall forfeit such contest to its opponent,” the conference said.
Weiterlesen »
FDA Authorizes Covid-19 Boosters for Certain ImmunocompromisedThe agency cleared giving a third dose of a Covid-19 vaccine from Pfizer or Moderna to certain immunocompromised people, likely the launch of broader efforts to better protect against evasive variants like Delta.
Weiterlesen »
FDA OKs 3rd COVID-19 vaccine dose for immunocompromised peopleThe onus will now shift to the CDC, which must decide whether to formally recommend the extra doses.
Weiterlesen »
FDA Authorizes Extra Covid-19 Vaccine Dose For Those With Weakened Immune SystemsThe FDA's decision comes at a time when the U.S. is hit by a new wave of infections fueled by the more infectious delta variant.
Weiterlesen »
Japan's Q3 growth forecast slashed on COVID-19 surgeJapan's economy will grow this quarter at a much slower pace than previously expected as a resurgence in coronavirus infections is hurting the momentum for a recovery, a Reuters poll found.
Weiterlesen »